Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

Abstract Title:

The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance.

Abstract Source:

Am J Hypertens. 2009 Jun;22(6):586-92. Epub 2009 Mar 19. PMID: 19300425

Abstract Author(s):

Gerasimos Siasos, Dimitris Tousoulis, Charalambos Vlachopoulos, Charalambos Antoniades, Elli Stefanadi, Nikos Ioakeimidis, Kostas Zisimos, Zoi Siasou, Athanasios G Papavassiliou, Christodoulos Stefanadis

Article Affiliation:

Department of Biological Chemistry, Athens University Medical School, Athens, Greece.

Abstract:

BACKGROUND: Smoking is associated with endothelial dysfunction and increased inflammatory status. The amino acid L-arginine, improves endothelial function in patients with cardiovascular risk factors. We investigated the effect of L-arginine on vascular function and inflammatory process in healthy smokers at rest and after acute smoking.

METHODS: We studied the effect of L-arginine and/or placebo in 12 healthy young smokers on three occasions (day 0, day 1, and day 3). The study was carried out on two separate arms, one with L-arginine (3 x 7 g/day) and one with placebo, according to a randomized, placebo-controlled, double-blind, cross-over design. Measurements were carried out before, immediately after, and 20 min after cigarette smoking. Endothelial function was evaluated by flow-mediated dilation (FMD). Carotid-femoral pulse wave velocity (PWV) was measured as an index of aortic stiffness and augmentation index (AIx) and as a measure of arterial wave reflections. Serum soluble intercellular adhesion molecule-1 (sICAM-1) was measured.

RESULTS: Compared to placebo, L-arginine improved FMD (P<0.01 at day 1 and P<0.05 at day 3). L-Arginine reduced PWV and AIx at both days 1 and 3 (P<0.05 vs. baseline). L-Arginine blunted the acute smoking-induced increase of AIx at both day 1 (P<0.05) and day 3 (P<0.01), and prevented the smoking-induced elevation of PWV at day 3 (P<0.05). Importantly, L-arginine reduced sICAM-1 at days 1 and 3 (P<0.05 for both vs. baseline).

CONCLUSIONS: Oral L-arginine improves endothelial function and vascular elastic properties of the arterial tree during the acute phase of smoking, an effect accompanied by reduced sICAM-1 levels in these subjects.

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.